Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Aug 5;15(15):1965.
doi: 10.3390/diagnostics15151965.

The Role of Quantitative EEG in the Diagnosis of Alzheimer's Disease

Affiliations
Review

The Role of Quantitative EEG in the Diagnosis of Alzheimer's Disease

Vasileios Papaliagkas. Diagnostics (Basel). .

Abstract

Alzheimer's disease is the most prevalent neurodegenerative disorder leading to progressive cognitive decline and functional impairment. Although advanced neuroimaging and cerebrospinal fluid biomarkers have improved early detection, their high costs, invasiveness, and limited accessibility restrict universal screening. Quantitative electroencephalography (qEEG) offers a non-invasive and cost-effective alternative for assessing neurophysiological changes associated with AD. This review critically evaluates current evidence on EEG biomarkers, including spectral, connectivity, and complexity measures, discussing their pathophysiological basis, diagnostic accuracy, and clinical utility in AD. Limitations and future perspectives, especially in developing standardized protocols and integrating machine learning techniques, are also addressed.

Keywords: Alzheimer’s disease; qEEG; spectral analysis.

PubMed Disclaimer

Conflict of interest statement

The author declares no conflict of interest.

Figures

Figure 1
Figure 1
Power Spectral Density Map for (a) AD patients and (b) Controls. Figure adapted by Simfukwe C et al. [32], CC License 3.0.

Similar articles

References

    1. Prince M., Wimo A., Guerchet M., Ali G.C., Wu Y.-T., Prina M.W. World Alzheimer Report 2015: The Global Impact of Dementia. Alzheimer’s Disease International; London, UK: 2015.
    1. Brookmeyer R., Johnson E., Ziegler-Graham K., Arrighi H.M. Forecasting the global burden of Alzheimer’s disease. Alzheimer’s Dement. 2007;3:186–191. doi: 10.1016/j.jalz.2007.04.381. - DOI - PubMed
    1. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer’s disease: Progress and problems. Science. 2002;297:353–356. doi: 10.1126/science.1072994. - DOI - PubMed
    1. Jack C.R., Jr., Knopman D.S., Jagust W.J., Shaw L.M., Aisen P.S., Weiner M.W., Petersen R.C., Trojanowski J.Q. ypothetical model of dynamic biomarkers of the Alzheimer’s disease pathological cascade. Lancet Neurol. 2010;9:119–128. doi: 10.1016/S1474-4422(09)70299-6. - DOI - PMC - PubMed
    1. McKhann G., Knopman D.S., Chertkow H., Hyman B.T., Jack C.R., Jr., Kawas C.H., Klunk W.E., Koroshetz W.J., Manly J.J., Mayeux R., et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups. Alzheimer’s Dement. 2011;7:263–266. doi: 10.1016/j.jalz.2011.03.005. - DOI - PMC - PubMed

LinkOut - more resources